Search
Search
Close this search box.

Malaysia makes moves to widen access to medical cannabis

Home » Malaysia makes moves to widen access to medical cannabis

Recent developments in Thailand may have sparked a domino effect in Asia, as Malaysia – where the death penalty still exists for possession of cannabis – starts conversations about legalisation.

This article was originally published via Cannareporter and is republished here with permission.

Malaysia may consider legalising cannabis for medicinal purposes, a Ministry of Health official told Reuters earlier this month.

Neighboring Thailand’s recent cannabis change in policy may well be to thank for the interest in legalising the medical use of cannabis in Malaysia, where the death penalty still applies to anyone possessing more than 200g of cannabis.

The discussion on possible legalisation came after Thai Public Health Minister, Anutin Charnvirakul, announced that he would meet with his Malaysian counterpart during a meeting of APEC health ministers next week, where Thailand will showcase the outcomes of its programme.

Read more: Thailand becomes first country in Asia to decriminalise cannabis

Thailand legalised medicinal cannabis in 2018 and in June, became the first Asian nation to decriminalise cultivation and its consumption in food and drink.

“We are developing our own framework for the use of cannabis for medicinal purposes and we want to learn from Thailand,” a Malaysian Ministry of Health official told Reuters anonymously.

Health Minister Khairy Jamaluddin said the Malaysian government welcomed clinical trials for the medical use of cannabidiol (CBD). According to Reuters, the state news agency reported last month that the Ministry of Health intended to start registering some CBD products next year after studying their safety, although approval for cultivation is still a ways off.

The cultivation and recreational use of cannabis is still illegal in Malaysia, with the possession of more than 200g (seven ounces) carrying a mandatory death sentence.

However, Health Minister Khairy Jamaluddin has said the import and use of medical cannabis under a doctor’s prescription is permissible if it is registered and licensed with the Drug Control Authority. 

Thailand’s extraordinary turnaround

Thailand has radically changed its cannabis policy in recent months, with the Minister of Public Health, Anutin Charnvirakul, investing in the industry for the country’s economic recovery – and has even been seen publicly appearing in cannabis shirts.

Seen as the “main driver of the legalisation of cannabis for medicinal purposes” in his country, the Thai minister estimates that the industry could be worth more than €3bn in five years. 

However, the sudden “legalisation” also brought some revolt, with several doctors calling for an immediate end to recreational use in the country.

At a press conference in Bangkok, Anutin revealed his desire to expand the policy to other Asian countries.

“Topics of discussion will be on how to jointly move forward this kind of policy in order to create benefits, economically and medically,” said Anutin, Reuters reported.

“We want everyone to recognise the property of this cannabis plant. The more people are interested in this field, the more development and research (it) will create.”

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?